Add-on Study for Protocol G200802 (NCT02463032): Effect of GTx-024 on Maximal Neuromuscular Function and Lean Body Mass
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 04 Aug 2017
At a glance
- Drugs Enobosarm (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors GTx
- 31 Jul 2017 Status changed from recruiting to active, no longer recruiting.
- 14 Mar 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Dec 2017.
- 14 Mar 2017 Status changed from not yet recruiting to recruiting.